Design Therapeutics, Inc. DSGN Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Design Therapeutics, Inc.’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s other income (expense)?
- Design Therapeutics, Inc. (DSGN) reported other income (expense) of $3.21M in Q3 2024.
- How has Design Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Design Therapeutics, Inc.'s other income (expense) increased by 5.7% year-over-year, from $3.03M to $3.21M.
- What is the long-term trend for Design Therapeutics, Inc.'s other income (expense)?
- Over 2 years (2021 to 2023), Design Therapeutics, Inc.'s other income (expense) has grown at a 516.6% compound annual growth rate (CAGR), from $298K to $11.33M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.